Mayo Alumni Magazine 2002 Spring - MC4409-0402 - Mayo Clinic

“We bring forth knowledge on both the mechanism of the disease
in question and a drug or device’s potential to alter the disease.”
— Stephen Kopecky, M.D.
Practical application
Mayo Physician Alliance for Clinical Trials is successful
in making certain its studies fit current clinical practice.
“We bring forth knowledge on both the mechanism of the
disease in question and a drug or device’s potential to alter
the disease,” says Dr. Kopecky. “That knowledge can then
be applied in conjunction with current medical treatment.”
The alliance offers a program that develops the idea, has
the clinicians, the infrastructure to support clinical trials
and the expertise in regulatory affairs. “Mayo has a
tremendous number of strengths,” says Dr. Kopecky.
Recently, the alliance has begun to publish articles and
advertise in journals and relevant clinical publications to
share results and information. Dr. Kopecky says Mayo
Physician Alliance for Clinical Trials wants to grow in the
next 10 years in its ability to coordinate studies in multiple
diseases and specialty areas — including disciplines such
psychiatry and pediatrics — while continuing core disease
research.
“We are always looking for ways in which we can help
the patient,” he says.
— Michael Dougherty
MPACT
MPACT
MPACT
MPACT
For more information about the Mayo Physician
Alliance for Clinical Trials contact:
www.mayo.edu/mpact/
Investigators
For investigators who wish to enroll in
Mayo Physician Alliance for Clinical Trials:
1-800-541-5815
Sponsors
For sponsors who wish to place a trial with Mayo
Physician Alliance for Clinical Trials:
1-800-541-5815 or e-mail: mpact@mayo.edu
16 Mayo Alumni Spring 2002